Name | Number of supported studies | Average coverage | |
---|---|---|---|
lung | 19 studies | 35% ± 11% | |
brain | 18 studies | 54% ± 22% | |
peripheral blood | 16 studies | 34% ± 10% | |
eye | 11 studies | 47% ± 17% | |
intestine | 10 studies | 28% ± 14% | |
kidney | 9 studies | 32% ± 9% | |
heart | 5 studies | 37% ± 7% | |
lymph node | 5 studies | 31% ± 8% | |
liver | 5 studies | 43% ± 15% | |
bone marrow | 4 studies | 35% ± 12% | |
uterus | 4 studies | 40% ± 15% | |
breast | 4 studies | 30% ± 4% | |
adipose | 4 studies | 44% ± 14% | |
pancreas | 3 studies | 53% ± 25% | |
skin | 3 studies | 20% ± 5% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 4471.75 | 1445 / 1445 | 100% | 26.16 | 183 / 183 |
prostate | 100% | 4303.62 | 245 / 245 | 99% | 14.61 | 499 / 502 |
lung | 100% | 4927.68 | 578 / 578 | 99% | 12.77 | 1144 / 1155 |
thymus | 100% | 4973.36 | 653 / 653 | 99% | 12.87 | 596 / 605 |
breast | 100% | 5273.74 | 459 / 459 | 98% | 17.85 | 1101 / 1118 |
ovary | 100% | 6431.65 | 180 / 180 | 98% | 9.17 | 420 / 430 |
brain | 100% | 4085.11 | 2638 / 2642 | 98% | 13.70 | 688 / 705 |
stomach | 100% | 3697.53 | 359 / 359 | 96% | 15.05 | 274 / 286 |
pancreas | 100% | 2770.18 | 327 / 328 | 96% | 10.31 | 171 / 178 |
intestine | 100% | 4590.40 | 966 / 966 | 95% | 10.84 | 500 / 527 |
uterus | 100% | 5782.48 | 170 / 170 | 95% | 9.50 | 435 / 459 |
bladder | 100% | 4688.33 | 21 / 21 | 95% | 9.50 | 477 / 504 |
kidney | 100% | 2739.67 | 89 / 89 | 94% | 11.20 | 850 / 901 |
adrenal gland | 100% | 4668.88 | 258 / 258 | 90% | 11.52 | 208 / 230 |
skin | 100% | 4996.47 | 1807 / 1809 | 88% | 10.40 | 416 / 472 |
liver | 99% | 1412.19 | 223 / 226 | 60% | 3.75 | 243 / 406 |
blood vessel | 100% | 6236.60 | 1335 / 1335 | 0% | 0 | 0 / 0 |
muscle | 100% | 3943.37 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 4179.89 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 3.16 | 1 / 1 |
adipose | 100% | 5230.00 | 1203 / 1204 | 0% | 0 | 0 / 0 |
heart | 98% | 3142.55 | 847 / 861 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 93% | 9.83 | 42 / 45 |
lymph node | 0% | 0 | 0 / 0 | 90% | 9.33 | 26 / 29 |
peripheral blood | 74% | 2701.31 | 689 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 54% | 3.82 | 43 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006325 | Biological process | chromatin organization |
GO_0006366 | Biological process | transcription by RNA polymerase II |
GO_0006281 | Biological process | DNA repair |
GO_0007283 | Biological process | spermatogenesis |
GO_0060009 | Biological process | Sertoli cell development |
GO_1904908 | Biological process | negative regulation of maintenance of mitotic sister chromatid cohesion, telomeric |
GO_0030900 | Biological process | forebrain development |
GO_0072711 | Biological process | cellular response to hydroxyurea |
GO_0035264 | Biological process | multicellular organism growth |
GO_0072520 | Biological process | seminiferous tubule development |
GO_0006338 | Biological process | chromatin remodeling |
GO_0006334 | Biological process | nucleosome assembly |
GO_0000212 | Biological process | meiotic spindle organization |
GO_0010571 | Biological process | positive regulation of nuclear cell cycle DNA replication |
GO_0030330 | Biological process | DNA damage response, signal transduction by p53 class mediator |
GO_0031509 | Biological process | subtelomeric heterochromatin formation |
GO_0031297 | Biological process | replication fork processing |
GO_0070198 | Biological process | protein localization to chromosome, telomeric region |
GO_0032206 | Biological process | positive regulation of telomere maintenance |
GO_0070192 | Biological process | chromosome organization involved in meiotic cell cycle |
GO_0006355 | Biological process | regulation of DNA-templated transcription |
GO_0035128 | Biological process | post-embryonic forelimb morphogenesis |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0000228 | Cellular component | nuclear chromosome |
GO_0000792 | Cellular component | heterochromatin |
GO_0005654 | Cellular component | nucleoplasm |
GO_0016604 | Cellular component | nuclear body |
GO_0005721 | Cellular component | pericentric heterochromatin |
GO_0016605 | Cellular component | PML body |
GO_0099115 | Cellular component | chromosome, subtelomeric region |
GO_0000779 | Cellular component | condensed chromosome, centromeric region |
GO_0000781 | Cellular component | chromosome, telomeric region |
GO_0005634 | Cellular component | nucleus |
GO_0035064 | Molecular function | methylated histone binding |
GO_0004386 | Molecular function | helicase activity |
GO_0042393 | Molecular function | histone binding |
GO_0003682 | Molecular function | chromatin binding |
GO_0070087 | Molecular function | chromo shadow domain binding |
GO_0015616 | Molecular function | DNA translocase activity |
GO_0046872 | Molecular function | metal ion binding |
GO_0005524 | Molecular function | ATP binding |
GO_0031490 | Molecular function | chromatin DNA binding |
GO_0140658 | Molecular function | ATP-dependent chromatin remodeler activity |
GO_0005515 | Molecular function | protein binding |
GO_0016887 | Molecular function | ATP hydrolysis activity |
Gene name | ATRX |
Protein name | Transcriptional regulator ATRX (EC 3.6.4.12) (ATP-dependent helicase ATRX) (X-linked helicase II) (X-linked nuclear protein) (XNP) (Znf-HX) Alternative protein ATRX Transcriptional regulator ATRX (ATP-dependent helicase ATRX) (X-linked nuclear protein) Alpha thalassemia/mental retardation syndrome X-linked (RAD54 homolog, S. cerevisiae) Transcriptional regulator ATRX (EC 3.6.4.12) (ATP-dependent helicase ATRX) (X-linked nuclear protein) ATRX chromatin remodeler Alpha thalassemia/mental retardation syndrome X-linked protein |
Synonyms | RP5-875J14.1-007 XH2 RP5-875J14.1-004 RAD54L |
Description | FUNCTION: Involved in transcriptional regulation and chromatin remodeling. Facilitates DNA replication in multiple cellular environments and is required for efficient replication of a subset of genomic loci. Binds to DNA tandem repeat sequences in both telomeres and euchromatin and in vitro binds DNA quadruplex structures. May help stabilizing G-rich regions into regular chromatin structures by remodeling G4 DNA and incorporating H3.3-containing nucleosomes. Catalytic component of the chromatin remodeling complex ATRX:DAXX which has ATP-dependent DNA translocase activity and catalyzes the replication-independent deposition of histone H3.3 in pericentric DNA repeats outside S-phase and telomeres, and the in vitro remodeling of H3.3-containing nucleosomes. Its heterochromatin targeting is proposed to involve a combinatorial readout of histone H3 modifications (specifically methylation states of H3K9 and H3K4) and association with CBX5. Involved in maintaining telomere structural integrity in embryonic stem cells which probably implies recruitment of CBX5 to telomeres. Reports on the involvement in transcriptional regulation of telomeric repeat-containing RNA (TERRA) are conflicting; according to a report, it is not sufficient to decrease chromatin condensation at telomeres nor to increase expression of telomeric RNA in fibroblasts . May be involved in telomere maintenance via recombination in ALT (alternative lengthening of telomeres) cell lines. Acts as a negative regulator of chromatin incorporation of transcriptionally repressive histone MACROH2A1, particularily at telomeres and the alpha-globin cluster in erythroleukemic cells. Participates in the allele-specific gene expression at the imprinted IGF2/H19 gene locus. On the maternal allele, required for the chromatin occupancy of SMC1 and CTCTF within the H19 imprinting control region (ICR) and involved in esatblishment of histone tails modifications in the ICR. May be involved in brain development and facial morphogenesis. Binds to zinc-finger coding genes with atypical chromatin signatures and regulates its H3K9me3 levels. Forms a complex with ZNF274, TRIM28 and SETDB1 to facilitate the deposition and maintenance of H3K9me3 at the 3' exons of zinc-finger genes . . |
Accessions | ENST00000493470.2 A4LAA3 A0A6Q8PHA4 L8E6W5 A0A068A261 Q5JX93 ENST00000625063.3 A0A096LPG6 A0A068A230 Q86U63 A0A096LNL7 ENST00000623316.1 A0A096LNX6 ENST00000624032.3 ENST00000624668.3 L8E8D0 ENST00000480283.5 ENST00000400866.4 A0A096LNN3 H0Y3T0 ENST00000395603.7 [P46100-4] ENST00000675732.1 A0A096LNR8 A0A096LP59 A0A087WWG0 A0A096LNL6 P46100 ENST00000623321.3 ENST00000624166.3 A0A067XLH7 ENST00000622960.1 A0A096LNW1 A0A096LNL9 ENST00000373344.11 [P46100-1] Q5H9A3 ENST00000623242.3 |